世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non Insulin Anti diabetes Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4583
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、インスリン非依存型糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・インスリン非依存型糖尿病治療薬の市場動向
・企業の競争状況、市場シェア
・インスリン非依存型糖尿病治療薬の種類別市場規模と予測2016-2027（経口薬、注射薬）
・インスリン非依存型糖尿病治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・インスリン非依存型糖尿病治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・インスリン非依存型糖尿病治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・インスリン非依存型糖尿病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・インスリン非依存型糖尿病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・インスリン非依存型糖尿病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Abbott、AstraZeneca、Eli Lilly、Roche、GlaxoSmithKline、Johnson & Johnson、Novartis）
・結論

Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes).

Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market
The global Non Insulin Anti diabetes Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non Insulin Anti diabetes Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non Insulin Anti diabetes Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non Insulin Anti diabetes Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non Insulin Anti diabetes Drugs market.

Global Non Insulin Anti diabetes Drugs Scope and Market Size
Non Insulin Anti diabetes Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non Insulin Anti diabetes Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Drugs
Injectable Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Abbott
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Johnson & Johnson
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non Insulin Anti diabetes Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drugs
1.2.3 Injectable Drugs
1.3 Market by Application
1.3.1 Global Non Insulin Anti diabetes Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non Insulin Anti diabetes Drugs Market Perspective (2016-2027)
2.2 Non Insulin Anti diabetes Drugs Growth Trends by Regions
2.2.1 Non Insulin Anti diabetes Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non Insulin Anti diabetes Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Non Insulin Anti diabetes Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Non Insulin Anti diabetes Drugs Industry Dynamic
2.3.1 Non Insulin Anti diabetes Drugs Market Trends
2.3.2 Non Insulin Anti diabetes Drugs Market Drivers
2.3.3 Non Insulin Anti diabetes Drugs Market Challenges
2.3.4 Non Insulin Anti diabetes Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non Insulin Anti diabetes Drugs Players by Revenue
3.1.1 Global Top Non Insulin Anti diabetes Drugs Players by Revenue (2016-2021)
3.1.2 Global Non Insulin Anti diabetes Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Non Insulin Anti diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non Insulin Anti diabetes Drugs Revenue
3.4 Global Non Insulin Anti diabetes Drugs Market Concentration Ratio
3.4.1 Global Non Insulin Anti diabetes Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non Insulin Anti diabetes Drugs Revenue in 2020
3.5 Non Insulin Anti diabetes Drugs Key Players Head office and Area Served
3.6 Key Players Non Insulin Anti diabetes Drugs Product Solution and Service
3.7 Date of Enter into Non Insulin Anti diabetes Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non Insulin Anti diabetes Drugs Breakdown Data by Type
4.1 Global Non Insulin Anti diabetes Drugs Historic Market Size by Type (2016-2021)
4.2 Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Type (2022-2027)

5 Non Insulin Anti diabetes Drugs Breakdown Data by Application
5.1 Global Non Insulin Anti diabetes Drugs Historic Market Size by Application (2016-2021)
5.2 Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non Insulin Anti diabetes Drugs Market Size (2016-2027)
6.2 North America Non Insulin Anti diabetes Drugs Market Size by Type
6.2.1 North America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021)
6.2.2 North America Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027)
6.2.3 North America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2027)
6.3 North America Non Insulin Anti diabetes Drugs Market Size by Application
6.3.1 North America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021)
6.3.2 North America Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027)
6.3.3 North America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2027)
6.4 North America Non Insulin Anti diabetes Drugs Market Size by Country
6.4.1 North America Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021)
6.4.2 North America Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non Insulin Anti diabetes Drugs Market Size (2016-2027)
7.2 Europe Non Insulin Anti diabetes Drugs Market Size by Type
7.2.1 Europe Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021)
7.2.2 Europe Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027)
7.2.3 Europe Non Insulin Anti diabetes Drugs Market Size by Type (2016-2027)
7.3 Europe Non Insulin Anti diabetes Drugs Market Size by Application
7.3.1 Europe Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021)
7.3.2 Europe Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027)
7.3.3 Europe Non Insulin Anti diabetes Drugs Market Size by Application (2016-2027)
7.4 Europe Non Insulin Anti diabetes Drugs Market Size by Country
7.4.1 Europe Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021)
7.4.2 Europe Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size (2016-2027)
8.2 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type
8.2.1 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application
8.3.1 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Region
8.4.1 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non Insulin Anti diabetes Drugs Market Size (2016-2027)
9.2 Latin America Non Insulin Anti diabetes Drugs Market Size by Type
9.2.1 Latin America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2027)
9.3 Latin America Non Insulin Anti diabetes Drugs Market Size by Application
9.3.1 Latin America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2027)
9.4 Latin America Non Insulin Anti diabetes Drugs Market Size by Country
9.4.1 Latin America Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size (2016-2027)
10.2 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type
10.2.1 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application
10.3.1 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Country
10.4.1 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Non Insulin Anti diabetes Drugs Introduction
11.1.4 Sanofi Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Non Insulin Anti diabetes Drugs Introduction
11.2.4 Abbott Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Non Insulin Anti diabetes Drugs Introduction
11.3.4 AstraZeneca Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Non Insulin Anti diabetes Drugs Introduction
11.4.4 Eli Lilly Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Non Insulin Anti diabetes Drugs Introduction
11.5.4 Roche Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Non Insulin Anti diabetes Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Non Insulin Anti diabetes Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Non Insulin Anti diabetes Drugs Introduction
11.8.4 Novartis Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021)
11.8.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non Insulin Anti diabetes Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Injectable Drugs
Table 4. Global Non Insulin Anti diabetes Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Non Insulin Anti diabetes Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non Insulin Anti diabetes Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2016-2021)
Table 8. Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2022-2027)
Table 10. Non Insulin Anti diabetes Drugs Market Trends
Table 11. Non Insulin Anti diabetes Drugs Market Drivers
Table 12. Non Insulin Anti diabetes Drugs Market Challenges
Table 13. Non Insulin Anti diabetes Drugs Market Restraints
Table 14. Global Non Insulin Anti diabetes Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Non Insulin Anti diabetes Drugs Market Share by Players (2016-2021)
Table 16. Global Top Non Insulin Anti diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Insulin Anti diabetes Drugs as of 2020)
Table 17. Ranking of Global Top Non Insulin Anti diabetes Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Non Insulin Anti diabetes Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non Insulin Anti diabetes Drugs Product Solution and Service
Table 21. Date of Enter into Non Insulin Anti diabetes Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Non Insulin Anti diabetes Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Non Insulin Anti diabetes Drugs Product
Table 64. Sanofi Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Non Insulin Anti diabetes Drugs Product
Table 69. Abbott Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Non Insulin Anti diabetes Drugs Product
Table 74. AstraZeneca Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Non Insulin Anti diabetes Drugs Product
Table 79. Eli Lilly Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Non Insulin Anti diabetes Drugs Product
Table 84. Roche Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Non Insulin Anti diabetes Drugs Product
Table 89. GlaxoSmithKline Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Non Insulin Anti diabetes Drugs Product
Table 94. Johnson & Johnson Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Revenue in Non Insulin Anti diabetes Drugs Business (2016-2021) & (US$ Million)
Table 99. Novartis Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non Insulin Anti diabetes Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Drugs Features
Figure 3. Injectable Drugs Features
Figure 4. Global Non Insulin Anti diabetes Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Non Insulin Anti diabetes Drugs Report Years Considered
Figure 9. Global Non Insulin Anti diabetes Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Non Insulin Anti diabetes Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Non Insulin Anti diabetes Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2022-2027)
Figure 13. Global Non Insulin Anti diabetes Drugs Market Share by Players in 2020
Figure 14. Global Top Non Insulin Anti diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Insulin Anti diabetes Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Non Insulin Anti diabetes Drugs Revenue in 2020
Figure 16. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Non Insulin Anti diabetes Drugs Market Share by Type (2016-2027)
Figure 20. North America Non Insulin Anti diabetes Drugs Market Share by Application (2016-2027)
Figure 21. North America Non Insulin Anti diabetes Drugs Market Share by Country (2016-2027)
Figure 22. United States Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Non Insulin Anti diabetes Drugs Market Share by Type (2016-2027)
Figure 26. Europe Non Insulin Anti diabetes Drugs Market Share by Application (2016-2027)
Figure 27. Europe Non Insulin Anti diabetes Drugs Market Share by Country (2016-2027)
Figure 28. Germany Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Non Insulin Anti diabetes Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Non Insulin Anti diabetes Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Non Insulin Anti diabetes Drugs Market Share by Region (2016-2027)
Figure 38. China Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Non Insulin Anti diabetes Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Non Insulin Anti diabetes Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Non Insulin Anti diabetes Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Non Insulin Anti diabetes Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Non Insulin Anti diabetes Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Non Insulin Anti diabetes Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Non Insulin Anti diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 58. Abbott Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年）

Global Oral Anti-diabetes Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4619 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、経口抗糖尿病薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（液体、カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetes Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5701 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、GLP-1、インスリン）、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のアンチエイジング薬＆デバイス市場規模・現状・予測（2021年-2027年）

Global Anti-Aging Drugs and Devices Market Size, Status and Forecast 2021-2027
QFJ1-3817 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、アンチエイジング薬＆デバイスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、デバイス）、用途別市場規模（皮膚＆髪の毛、骨格＆筋肉、加齢性障害など）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の抗パーキンソン薬市場規模・現状・予測（2021年-2027年）

Global Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5587 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、抗パーキンソン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドーパミン作動薬、ドーパミン作動薬、酵素阻害薬、その他）、用途別市場規模（病院薬局、小売薬局、オンラインストア）、主要地域別市場規模（北...

世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年）

Global Anti-Asthmatics and COPD Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3819 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、抗喘息薬＆COPD薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年）

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2021-2027
QFJ1-4594 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、非ステロイド性抗炎症薬（NSAID）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他）、用途別市場規模（ドラッグストア、病院薬局、オンライ...

世界の動物用インスリン市場規模・現状・予測（2021年-2027年）

Global Animal Insulin Market Size, Status and Forecast 2021-2027
QFJ1-3811 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、動物用インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブタインスリン、ウシインスリン）、用途別市場規模（人間、動物）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のプレミックスインスリン市場規模・現状・予測（2021年-2027年）

Global Premix Insulin Market Size, Status and Forecast 2021-2027
QFJ1-4756 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、プレミックスインスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プレミックスヒトインスリン、プレミックスインスリンアナログ）、用途別市場規模（家庭、医療機関、その他）、主要地域別市場規模（北米、...

世界の1型糖尿病治療市場規模・現状・予測（2021年-2027年）

Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4993 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、1型糖尿病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（速効型インスリン、速効型インスリン、その他）、用途別市場規模（病院・診療所、学術研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のインスリンペン＆ペンニードル市場規模・現状・予測（2021年-2027年）

Global Insulin Pen and Pen Needle Market Size, Status and Forecast 2021-2027
QFJ1-5214 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、インスリンペン＆ペンニードルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インスリンペン、ペンニードル）、用途別市場規模（家庭用、医療機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …
世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications. Market Analysis and Insights: Global Diab…
世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年） The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The cla…
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Injectable Anthelmintic Drugs Market The global Injectable Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…